Liquidia Corporation Common Stock (LQDA) is a publicly traded Healthcare sector company. As of November 18, 2026, LQDA trades at $56.44 with a market cap of $5.11B and a P/E ratio of 17.45. LQDA moved -0.56% today. Year to date, LQDA is +75.51%; over the trailing twelve months it is +86.84%. Its 52-week range spans $11.26 to $93.61. Analyst consensus is strong buy with an average price target of $64.13. Rallies surfaces LQDA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for LQDA, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $56.44 |
| Market Cap | $5.11B |
| P/E Ratio | 17.45 |
| EPS | $1.57 |
| Dividend Yield | 0.00% |
| 52-Week High | $93.61 |
| 52-Week Low | $11.26 |
| Volume | 1.00M |
| Avg Volume | 0 |
| Revenue (TTM) | $450.91M |
| Net Income | $138.61M |
| Gross Margin | 0.00% |
8 analysts cover LQDA: 0 strong buy, 6 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $64.13.